课题基金 / 基金详情

Elucidation of the resistance mechanisms of immunotherapy by the abnormal signal transduction in melanoma and development of methods to overcome it

Elucidation of the resistance mechanisms of immunotherapy by the abnormal signal transduction in melanoma and development of methods to overcome it
阐明黑色素瘤中异常信号转导引起的免疫治疗耐药机制并开发克服该机制的方法
批准号:
21591445
负责人:
SAKURAI Toshiharu
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

SAKURAI Toshiharu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study, we have attempted to identify new signaling molecules which trigger multiple immunosuppressive and tumor promoting cytokines and chemokines. By screening dendritic cell(DC) suppressing activity of culture supernatants from the human melanoma cell line treated with human kinase siRNA library, we found 7 kinases. One of them, Serine/Threonine kinase 24(STK24), was found to induce production of IL10, TGF-β, and CCL2 by human melanoma cells. Phosphorylated STK24 was increased in various human melanoma cell lines and melanoma tissue. These results indicate that activated STK24 in cancer cells is involved in the generation of tumor promoting and immunosuppressive tumor microenvironment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
悪性黒色腫および樹状細胞でのWnt/β-cateninシグナル亢進はがん微小環境での免疫抑制に関与する
恶性黑色素瘤和树突状细胞中 Wnt/β-catenin 信号增强参与癌症微环境中的免疫抑制
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [谷口智憲, 守井賢二, 西尾浩, 桜井敏晴, 塚本信夫, 工藤千恵, 藤田知信, 河上裕]
通讯作者: 河上裕
がん微小環境免疫抑制病態における樹状細胞STAT3の意義とその制御
树突状细胞STAT3及其调控在癌症微环境免疫抑制病理学中的意义
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [川村直, 梶原知子, 住本秀敏, 水口裕之, 竹田潔, 河上裕]
通讯作者: 河上裕
悪性黒色腫に対する免疫応答と免疫療法-最近の進歩-
恶性黑色素瘤的免疫反应和免疫治疗 - 最新进展 -
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Ohta S, Akamatsu W, Imaizumi Y, Okada Y, Matsuzaki Y, Okano H, Kawakami Y, 太田訓正, 河上裕]
通讯作者: 河上裕
Possible improvement of cancer immunotherapy based on the analyses of anti-tumor immune responses in human
基于人类抗肿瘤免疫反应的分析,癌症免疫治疗的可能改进
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [河上裕、工藤千恵, 他]
通讯作者:
18
    Molecular link between stress response and cancer and its clinical implication
    • 批准号:
      17K09396
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      SAKURAI Toshiharu
    • 依托单位:
    Novel molecular target in colorectal cancer and inflammatory bowel disease
    • 批准号:
      26460979
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2014
    • 负责人:
      SAKURAI Toshiharu
    • 依托单位:
    Translational research focusing on the regulation of proteasome by Gankyrin
    • 批准号:
      23590998
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      SAKURAI Toshiharu
    • 依托单位:
    The study of immunosuppressive mechanisms induced by gastrointestinal cancer during epithelial-mesnchymal transition and clinical application of this target therapy
    • 批准号:
      18591484
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.57万
    • 财政年份:
      2006
    • 负责人:
      SAKURAI Toshiharu
    • 依托单位:
    海外基金